US Patent Issued to Nanjing Ruijie Pharma on June 24 for "Compounds and their uses as thyroid hormone receptor agonists" (Chinese Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,206, issued on June 24, was assigned to Nanjing Ruijie Pharma Co. Ltd. (Jiangsu, China).

"Compounds and their uses as thyroid hormone receptor agonists" was invented by Junbo Zhang (Nanjing, China) and Xiaoxin Qi (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of formula (I) or (Ia), or a tautomer or a pharmaceutically acceptable salt thereof is provided. Compounds of formula (II) to (V), or a tautomer or a pharmaceutically acceptable salt thereof are also provided. These compounds and the pharmaceutical compositions containing them are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolem...